Fredun Pharmaceuticals (NSE:FREDUN) OCF Margin %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:FREDUN Fredun Pharmaceuticals Ltd NSE:FREDUN
60 GF Score
Price ₹1,428.00
GF Value ₹600.96
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fredun Pharmaceuticals OCF Margin %?

Fredun Pharmaceuticals NSE:FREDUN 60 OCF Margin % is 0.00% as of Jun. 2026. GuruFocus rates NSE:FREDUN with a GF Score™ of 60/100 and a GF Value™ of ₹600.96 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 960 Drug Manufacturers companies, Fredun Pharmaceuticals ranks worse than 70% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Fredun Pharmaceuticals's Cash Flow from Operations for the three months ended in Jun. 2026 was ₹0.00 Mil. Fredun Pharmaceuticals's Revenue for the three months ended in Jun. 2026 was ₹2,277.56 Mil. Therefore, Fredun Pharmaceuticals's OCF Margin % for the quarter that ended in Jun. 2026 was 0.00%.

As of today, Fredun Pharmaceuticals's current OCF Yield % is 0.51%.

The historical rank and industry rank for Fredun Pharmaceuticals's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Fredun Pharmaceuticals was 29.10%. The lowest was -9.45%. And the median was 0.00%.

NSE:FREDUN's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.785
* Ranked among companies with meaningful OCF Margin % only.

Fredun Pharmaceuticals OCF Margin % Related Terms

Fredun Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Fredun Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fredun Pharmaceuticals OCF Margin % Chart

Fredun Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.07 -5.25 -0.13 -3.67 1.88

Fredun Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:FREDUN
60GF Score
Fredun Pharmaceuticals Ltd NSE:FREDUN
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fredun Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Fredun Pharmaceuticals's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=119.015/6333.265
=1.88 %

Fredun Pharmaceuticals's OCF Margin for the quarter that ended in Jun. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=0/2277.555
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Fredun Pharmaceuticals (NSE:FREDUN) has a OCF Margin % of 0.00% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Fredun Pharmaceuticals and its competitors. According to the industry distribution chart, Fredun Pharmaceuticals ranks #672 out of 960 companies in the Drug Manufacturers industry, placing it in the top 70%.
Is Fredun Pharmaceuticals' OCF Margin % too high?
Fredun Pharmaceuticals' current OCF Margin % is 0.00%. Based on the distribution chart, Fredun Pharmaceuticals ranks #672 out of 960 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Fredun Pharmaceuticals has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fredun Pharmaceuticals' OCF Margin % compare to ?
According to the Drug Manufacturers industry distribution chart, Fredun Pharmaceuticals ranks #672 out of 960 companies for OCF Margin %. This places Fredun Pharmaceuticals in the lower half of its industry. The industry median OCF Margin % is 9.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.79, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Fredun Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fredun Pharmaceuticals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fredun Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Fredun Pharmaceuticals (NSE:FREDUN) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹600.96, compared to a current price of ₹1,428.00 — trading 137.6% above its estimated fair value. The current OCF Margin % is 0.00%. Fredun Pharmaceuticals' overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Fredun Pharmaceuticals (NSE:FREDUN), the current OCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fredun Pharmaceuticals (NSE:FREDUN) Overvalued in 2026?

Based on GuruFocus' analysis, Fredun Pharmaceuticals stock appears to be overvalued. The current stock price of ₹1,428.00 is trading 137.6% above its estimated GF Value™ of ₹600.96. GuruFocus considers Fredun Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:FREDUN:

  • OCF Margin %: 0.00%
  • GF Value™: ₹600.96 vs. price of ₹1,428.00 (137.6% above fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the NSE:FREDUN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fredun Pharmaceuticals Business Description

Comparable Companies
Other Exchanges 539730:India
Address Ganpatrao Kadam Marg, Delisle Road, 11th Floor, Urmi Estate 95, Lower Parel (West), Mumbai, MH, IND, 400013
Fredun Pharmaceuticals Ltd in its Endeavour to move ahead has now ventured into manufacturing of dietary /herbal supplements, nutraceuticals, and other healthcare products along with Animal Healthcare products also with products ranging from allopathic formulations to on field diagnostic kits, Company's main objective is to be a holistic healthcare provider. The group is dedicated to improving lives of people. The Company operates only in a single segment i.e. Pharmaceutical Segment. The company has presence in Domestic as well as International market. The company generates majority of revenue from Domestic market.
60GF Score

Get the complete analysis for NSE:FREDUN

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,428.00
Price
₹600.96
GF Value